Total reported value
$176.9M
Reporting period: 2026-03-31 · Number of holdings: 7
ANDERA PARTNERS disclosed 7 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $176.9M and a quarterly turnover rate of 34.3%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "A"
Trim MLYS
0.0% -$14.6M
Trim KMTS
+6.1% -$13.6M
Add EVMN
0.0% $11.1M
Trim ABVX
0.0% -$1.8M
Add IVA
0.0% $1.6M
New buy AGMB
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | KMTS | Kestra Medical Technologies, Ltd. | Stock-Other | 30.36% | -7.78% | +6.11% | |
| 2 | EVMN | Evommune INC | Stock-Other | 24.66% | +6.27% | — | |
| 3 | MLYS | Mineralys Therapeutics INC | Stock-Other | 24.38% | -8.33% | — | |
| 4 | AGMB | Agomab Therapeutics NV | Stock-Other | 9.12% | +9.12% | NEW | |
| 5 | IVA | Inventiva SA - Adr | Stock-Other | 5.70% | +0.91% | — | |
| 6 | ABVX | Abivax Sa-adr | Stock-Other | 4.92% | -1.05% | — | |
| 7 | ✓ | Nyxoah S A | Stock-Other | 0.86% | +0.86% | NEW |
Performance for Q3 2026
-4.9%
Performance Last 4 Quarters
-14.4%
Based on 5 months of available history
Not enough sector-mapped data yet
Andera Partners's most significant position changes for 2026-03-31: New buy: Agomab Therapeutics NV (AGMB); New buy: Nyxoah S A; Add: Kestra Medical Technologies, Ltd. (KMTS) — shares +6.11%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | EVMN | Evommune INC | +6.3% | — | Unchanged |
| 2 | IVA | Inventiva SA - Adr | +0.9% | — | Unchanged |
| 3 | ABVX | Abivax Sa-adr | -1.1% | — | Unchanged |
| 4 | KMTS | Kestra Medical Technologies, Ltd. | -7.8% | +6.11% | Add |
| 5 | MLYS | Mineralys Therapeutics INC | -8.3% | — | Unchanged |
| 6 | AGMB | Agomab Therapeutics NV | — | NEW | New buy |
| 7 | ✓ | Nyxoah S A | — | NEW | New buy |
Institutions with a similar AUM
CIK 0002005547
Total reported value
$176.9M
351 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001616882
Total reported value
$177.0M
14 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001998980
Total reported value
$177.0M
45 stks
2026-06-30
AUM within 0.1% of this institution
Institutions with overlapping top holdings
CIK 0001668029
Total reported value
$97.0M
8 stks
2026-03-31
2 of the top 5 holdings overlap, including Kestra Medical Technologies, Ltd.
CIK 0001834239
Total reported value
$1.0B
5 stks
2026-03-31
2 of the top 5 holdings overlap, including Evommune INC
CIK 0002006045
Total reported value
$52.8M
6 stks
2026-03-31
2 of the top 5 holdings overlap, including Evommune INC